13F Holdings
中文EN

ONMD OneMedNet Corp

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1849380 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY365.1%
TTM net income YoY-412.3%
TTM EPS YoY-14,000.0%
Revenue 3-yr CAGR33.7%
Net income 3-yr CAGR—

Margins

Gross margin-49.7%
Operating margin-440.0%
Net margin-452.9%
FCF margin-285.4%
EBITDA margin-438.6%

Returns

ROE—
ROA-506.7%
ROIC (approx.)—
Asset turnover1.12x

Leverage & solvency

Liabilities / assets277.5%
Debt / equity—
Current ratio0.38x
Interest coverage-289.40x

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio-188.2%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.36M$643,000$1.02M$1.15M—
Cost of revenue$1.86M$924,000$1.15M$1.51M—
Gross profit-$503,000-$281,000-$129,000-$360,000—
R&D expense$1.51M$1.47M$2.06M$1.59M—
SG&A expense$6.38M$7.03M$3.54M$4.81M—
Operating income-$9.67M-$9.61M-$6.85M-$7.71M—
Interest expense$67,000$147,000$11,000$403,307—
Pretax income-$2.80M-$10.13M-$33.76M-$30.43M—
Income tax$1,000$2,000$18,000$17,000—
Net income-$2.80M-$10.13M-$33.78M-$30.45M—
EBITDA-$9.60M-$9.55M-$6.83M-$7.69M—
EPS (basic)-0.06-0.36-4.65-7.66—
EPS (diluted)-0.06-0.36-4.65-7.66—
Weighted avg. shares (diluted)44.55M28.08M7.27M3.97M—
Balance sheet
Cash & equivalents$585,000$172,000$47,000$271,000$453,151
Receivables$495,000$213,000$152,000$19,000—
Current assets$2.10M$3.62M$365,000$391,000$536,212
PP&E, net$56,000$108,000$99,000$83,000—
Total assets$2.15M$3.73M$464,000$1.29M$117.86M
Current liabilities$4.83M$19.23M$13.84M$26.10M$289,980
Short-term debt$974,000$9.38M$465,000——
Long-term debt$220,000$2.32M$465,000——
Total debt$1.19M$11.70M$930,000——
Total liabilities$5.12M$19.68M$13.91M$27.65M$9.17M
Shareholders' equity-$2.96M-$15.95M-$13.44M-$26.36M-$7.05M
Net debt$609,000$11.53M$883,000——
Shares outstanding5.18M27.99M23.57M4.03M—
Cash flow statement
Operating cash flow-$7.50M-$6.95M-$4.79M-$4.70M—
Capital expenditure$13,000$51,000$44,000$58,000—
Free cash flow-$7.52M-$7.00M-$4.83M-$4.76M—
Investing cash flow$2.31M-$1.98M-$44,000-$58,000—
Financing cash flow$5.61M$9.06M$4.61M$4.33M—
Depreciation & amortization$65,000$57,000$28,000$25,000—
Stock-based compensation$2.03M$628,000$1.48M$1.86M$47,071

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.